AI MEDICAL SERVICE INC. (AIM), a pioneering medical startup specializing in the development of AI-driven diagnostic endoscopy, commenced a joint research endeavor with Thailand's Mahidol University. This collaboration marks a significant milestone as AIM becomes the first Japanese entity to partner with Mahidol in the realm of endoscopic AI, while Mahidol stands as AIM's inaugural Thai collaborator in this domain.
The primary objective of this joint effort is to evaluate the feasibility and effectiveness of AIM's endoscopic AI technology. AIM's proprietary AI-equipped endoscopic imaging diagnosis support system, which received regulatory approval from Japan's Minister of Health on December 23, 2023, has already entered the market in Japan and Singapore, with sales commencing in March 2024.
Seeking to broaden its global footprint, AIM is keen on extending its product reach to clinical facilities worldwide. The collaboration with Mahidol University offers a strategic avenue to explore the adaptability of Japanese endoscopic AI solutions within the healthcare landscape of Thailand. Mahidol University, renowned for its multidisciplinary excellence and longstanding heritage, serves as an ideal partner for AIM's aspirations in the Thai market.
CEO of AIM, Dr. Tomohiro Tada, expressed his enthusiasm for this collaboration, particularly emphasizing the significance of addressing the challenges associated with gastric cancer detection in the Asian region. With a high incidence of gastric cancer cases and related mortality rates, coupled with the complexities of early-stage detection, AIM aims to leverage its expertise in endoscopic medicine to contribute meaningfully to healthcare outcomes in Thailand.
In summary, AIM's partnership with Mahidol University underscores a shared commitment to advancing medical technology and improving patient care. Through collaborative research initiatives, AIM endeavors to seamlessly integrate its cutting-edge endoscopic AI solutions into clinical practice, thereby addressing critical healthcare challenges and enhancing diagnostic capabilities in Thailand and beyond.
